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Celiac Disease: its Neuropsychitric Manifestations and its Relevance to the Practicing
Pediatrician
Adam Daniel Zavodnick

Introductory Remarks and Objectives
Over the past two decades, the medical community’s understanding of celiac disease, also
known as gluten sensitivity, has evolved significantly. No longer just a GI problem, celiac
disease is now recognized as a multisystem autoimmune disorder. A growing body of distinct
neurological conditions such as cerebellar ataxia, epilepsy, myoclonic ataxia, chronic
neuropathies, migraine headache and dementia has been reported, mainly in middle-aged adults.
However, while much is known regarding the neuropsychiatric manifestations of celiac disease
in the adult population, less is understood about its presentation in the pediatric population. This
is especially true of the “soft” neurological conditions, such as headache, learning disorders,
attention-deficit/hyperactivity disorder (ADHD), and depression.
The aim of this paper is to briefly discuss the pathophysiology of celiac disease, describe
what is currently known about the neuro-psychiatric manifestations of celiac disease in children,
and discuss the potential benefits of more aggressive serologic testing.
Pathophysiology of Celiac Disease
Celiac disease is a unique autoimmune disorder most notably because the environmental
precipitants (gluten, hordein, secalin) are known (1). The symptoms of the disease manifest not
directly from the ingestion of gluten, but rather from the complex interaction between the
gastrointestinal system, enzymatically degraded components of gluten, and the immune system
of the individual.
The term “prolamins” technically refers to the protein component of certain kinds of
grain. These prolamins have a high content of the amino acids proline and glutamine. When
referring to the prolamins relevant to those with celiac disease, the term gluten is used loosely to
describe the protein fraction of wheat, rye and barley. This is technically incorrect because the
prolamins of barley and rye are known as hordein and secalin, respectively. This technical
oversite can be made because of the immunologic cross reactivity between the prolamins of
wheat, barley and rye (2).
The alcohol-soluble fraction of gluten is known as gliadin, while the alcohol insoluble
fraction is known as glutenin. It is the enzymatically modified gliadin fraction, which triggers the
immune response in individuals with celiac disease. This immune response ensues because the
gliadin fraction is resistant to degradation by gastric, pancreatic and intestinal brush-border
membrane proteases in the human intestine and thus remains in the intestinal lumen after gluten
ingestion. Gliadin peptides pass through the epithelial barrier of the intestine and are engulfed by
antigen-presenting cells (APCs) in the lamina propria. It is possible that passage of gliadin is
facilitated by intestinal infection, which would increase gastrointestinal permeability (1).
The inflammatory response which ensues causes the loss of villous architecture, which is the
hallmark histologic manifestation of celiac disease on intestinal biopsy as well as the
characteristic malabsorption, which cause many of the clinical findings of individuals with celiac
disease (e.g. anemia, low protein, nutrient deficiency). This inflammatory cascade is caused by
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both the innate and adaptive immune systems and results in the generation of antibodies against
gliadin and endomysial components, specifically transglutaminase (1).
A key to understanding celiac disease is that the elimination of gluten from the diet is
usually sufficient to terminate the inflammatory cascade, with eventual healing of the
gastrointestinal tract and decreased concentrations of antibodies characteristic of celiac disease.
This is in stark contrast to other environmentally induced pathologies, in which the process of
destruction is not reversible (e.g. radiation induced malignancy). That having been said, there are
certain sequelae of celiac disease, which may not be reversible, inclusive of certain psychiatric
manifestations to be more fully described later on.
Diagnosis of Disease
Diagnostic criteria for celiac disease vary from country to country, but the most
frequently used criteria for diagnosis include endoscopy, serologic investigation and
improvement of symptoms on initiation of a gluten-free diet. The term “silent or subclinical
celiac disease” refers to individuals who deny symptoms of celiac disease but whose serology
point to an immune response against gluten and have evidence of disease on biopsy. It is
important to note that many of these “silent” patients often do report feeling better on a glutenfree diet. The term “potential” celiac disease refers to those with positive serologies but benign
histologic biopsies (3). Treatment of those with “potential” celiac disease is controversial; see
recommendations further on in this article.
Epidemiology of Celiac Disease
Celiac disease is present not only in countries populated by persons of European ancestry
but also in the Middle East, Asia, South America and North Africa. It is most prevalent among
Caucasians and is most frequently diagnosed between the ages of 10-40. Occurrence of disease is
estimated to be 1% of the general population and it is believed that the majority of cases remain
undiagnosed. In the United States prevalence estimates range from 1:80 to 1:300 in children. Of
those individuals with no risk factors or perceived symptoms, estimates of disease prevalence are
suggested to be approximately 1:133. The ratio of asymptomatic to symptomatic cases has been
estimated by some investigators to be as high as 7:1 (3).
Between 8 and 10 percent of children with apparent “idiopathic” short stature have
serological evidence of celiac disease and patients with patient with gastrointestinal symptoms
have slightly attenuated adult height unless treated prior to puberty. Delay in linear growth may
occur even when weight for height ratios are fairly normal, and in the absence of significant
gastrointestinal symptoms. Thus it is likely that under nutrition cannot be completely to blame
(3).
Boys with untreated celiac disease are noted to have decreased levels of
dihydrotestosterone (DHT) in their serum, in a trend suggestive of androgen resistance.
Adolescent girls may have an increased frequency of menstrual abnormalities (e.g. delayed
menarche) and later may have problems with infertility and experience an early menopause.
Gluten-free diets appears to prevent these problems (3).
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High Risk Populations
Populations particularly at high risk for celiac disease include first and second degree
relatives of patients with celiac disease, patients with Down syndrome, patients with Turner
syndrome, IgA deficiency, Williams syndrome, and autoimmune thyroiditis. Individuals with
Down syndrome have the highest risk of disease, with up to 16% of the population being
affected, a 20-fold increase over the general population. Other groups may have 2-7% affected,
still a substantially higher incidence. Evidence and theories as to why these associations might be
are beyond the scope of this paper. Suffice it to say that many children with chronic care needs
will be at high risk for being diagnosed with celiac disease (3). It is worth noting however that
there is no evidence that individuals afflicted with autism are at increased risk for celiac disease
(4); this is despite the high popularity of gluten and casein free diets among parents caring for
children with autism.
Range of Neuropsychiatric Symptoms
Celiac disease may have as its primary manifestation neuropsychiatric symptoms (3).
Adults with celiac disease can present with symptoms such as ataxia, depression, anxiety,
epilepsy, and headache. Children also can manifest with neuropsychiatric manifestations but in
contrast with adults can also present with developmental delay, hypotonia, learning disorders.
Some of these symptoms such as developmental delay and hypotonia can be attributed to
malabsorption of specific nutrient deficiencies. These symptoms are likely the result of the
damaged gastrointestinal mucosa and it is not surprising that such symptoms should be reversible
upon initiation of a gluten-free diet and correction of the deficiencies (3).
However there is evidence for other mechanisms by which the inflammatory response of
the immune system might lead to neuropsychiatric manifestations of celiac disease.
Hadjivassiliou et al have published extensively on the neurologic manifestations of celiac disease
in adults and documented the existence of autoantibodies targeting transglutaminases (TG2) in
the brain and intestinal mucosa in patients with gluten ataxia (5). These autoantibodies were
most prevalent in the cerebellum, medulla and pons. IgA deposition and vasculitis in the
cerebellum can explain the ataxia in many patients with celiac disease and could potentially shed
light on other neuropsychiatric manifestations as well.
De Santis et al first described an individual with schizophrenic symptoms who had
evidence of cerebral hypoperfusion and celiac disease in 1997 (6). This prompted Addolorato et
al to further investigate perfusion in patients with untreated celiac disease, treated celiac disease
(gluten-free diet) and case controls and found those with untreated celiac disease were
significantly more likely to have areas of cerebral hypoperfusion. He found that brain
hypoperfusion was reversible with initiation of a gluten-free diet (7).
While these studies looked at adult patients, the mechanisms behind the cerebral
hypoperfusion could potentially extend to the pediatric population and explain many of the
neuropsychiatric manifestations of celiac disease in children inclusive of depression.
Zelnik et al found that the range of neuropsychiatric manifestations of celiac disease in the
pediatric population was quite broad and included chronic headache, developmental delay,
hypotonia and learning disorders or ADHD (4). In contrast with other findings, Zelnik concluded
that only migraine headache and transient infantile hypotonia could be corrected by institution of
a gluten-free diet.
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Speculations Regarding the Neuropsychiatric Manifestations of Celiac Disease
In looking through the rapidly growing body of evidence regarding the neuropsychiatric
manifestations of celiac disease it is clear the much remains to be learned regarding the exact
mechanisms by which individuals with celiac disease develop symptoms. Some symptoms can
be explained simply by nutrient deficiency, while others are perhaps the result of a vasculitis.
Other symptoms are perhaps the result of hypoperfusion. However, while there is still much we
do not know, it is clear that celiac disease is not simply a disease isolated to the gastrointestinal
system. Extra-intestinal symptoms are present in as many as 10% of those with celiac disease
(3). Furthermore it is not known how correctable all of these manifestations will be. Therefore it
behooves the practicing clinician to be vigilant to suspect celiac disease in patients presenting
with neuropsychiatric symptoms, even if GI symptoms are absent or minimized by the patient.
Relevance to the Pediatrician
The majority of research looking into the neuropsychiatric manifestations of celiac
disease involves adults. One should never assume that the trends in the pediatric population
mimic that of adults. The popular slogan that children are NOT little adults rings true in regards
to celiac disease as well. As previously stated, Zelnik et al did find many children with
neuropsychiatric symptoms who were afflicted with celiac disease. However, a recent
publication by Ruggieri et al found that the prevalence of neurologic/psychiatric manifestation in
children with celiac disease was only slightly higher than that in controls (8). In their discussion
the authors speculate that children may perhaps be protected against nervous system involvement
either by shorter duration of illness, strict adherence to a diet free of gluten or even a changing
antigen spectrum during normal growth and development.
Recommendations
In reviewing the literature in preparation for this paper it seems clear to this writer that
many with positive serologies suggestive of celiac disease may not be aware of any
gastrointestinal symptoms (indeed there may be none). It is also evident that those with celiac
disease on a gluten-free diet may not be as adherent as their caregivers would wish. It is also
clear that while endoscopy is an excellent tool for diagnosing celiac disease, serologic testing is
clearly easier, safer and very effective in its predictive value (3); while also useful in monitoring
the adherence to dietary restrictions.
It is my hope that more clinicians will consider serologic testing of asymptomatic
individuals who are at high risk for developing celiac disease (e.g. family history, Down
syndrome, Turner syndrome) as well as individuals who present with neuropsychiatric symptoms
such as ADHD, depression or migraine when there is any evidence of GI comorbidity in the
hopes of preventing the more dangerous complications of celiac disease (e.g. malignancy) and
more accurately treating the cause of their symptoms. As there is evidence that many of the
symptoms (inclusive of some neuropsychiatric symptoms) of celiac disease are reversible with
the initiation of a gluten free diet hopefully the earlier diagnosis of celiac disease will provide a
higher quality of life for those individuals afflicted with this fascinating autoimmune entity.
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The pediatrician should be aware that the exact prevalence and range of neuropsychiatric
manifestations in the pediatric population is not clearly established. However because of the fair
reliability of serologic testing, initial screening can be done without the need of GI referral or the
risks of endoscopy.
Many clinicians would argue against treating through diet those individuals with
“potential” celiac disease (serologic evidence but no histologic evidence of disease) but I would
consider it. Firstly, the neuropsychiatric symptoms experienced by those with celiac disease are
most likely not from antibodies damaging the gut but from those same antibodies doing damage
to the nervous system. Decreasing those antibody levels could potentially save the “potential”
celiac patient from becoming an active celiac patient and spare the nervous system from the
possible ravages of humoral immune deposition and/or hypoperfusion.
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